Iroko Pharmaceuticals, LLC Company Profile

04:24 EDT 28th October 2016 | BioPortfolio

Iroko is a pharmaceutical company focused on specialty therapeutic areas. The company acquires, develops and maximizes the potential of currently marketed products on a global basis through focused selling and marketing efforts and product-life-cycle management activities including development of new formulations to improve patient treatment.

News Articles [1538 Associated News Articles listed on BioPortfolio]

Louis J. Vollmer Named Iroko’s CEO

Iroko Pharmaceuticals LLC. has appointed Louis J. Vollmer president and CEO. Vollmer has been president of Iroko since March 2015...    

Iroko names Louis Vollmer president, CEO

David SalazarVollmer, who has been Iroko’s president since March 2015 has been in the pharmaceutical industry for more than 25 years, including his role as one of three founders of Endo Pharmace...

Iroko Pharmaceuticals Appoints Louis J. Vollmer as President and Chief Executive Officer

PHILADELPHIA, July 11, 2016 /PRNewswire/ -- Iroko Pharmaceuticals, LLC announced today the appointment of Louis J. Vollmer as President and Chief Executive Officer effective July 6, 2016. Mr. Vol...

Iroko Pharmaceuticals Secures Debt Financing From CRG

PHILADELPHIA, June 29, 2016 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company...

Lisa Nolan Joins Rexahn Pharmaceuticals

Cancer focused Rexahn Pharmaceuticals Inc. has appointed Lisa Nolan to the newly created position of chief business officer (CBO). She...   &#

Iroko financial update

Sentient Interactive Earns More Digital Marketing Awards

Sentient Interactive, LLC, a digital-first, metrics-driven marketing agency recently won more than 20 awards for its work in the life sciences, financial services, and B2B industries. Morristown, NJ (...

Jazz Pharmaceuticals Acquires Celator for $1.5B

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today announced that they have entered into a definitive agreement for Jazz Pharmaceuticals to acquire Celator ...

Drugs and Medications [0 Results]


PubMed Articles [149 Associated PubMed Articles listed on BioPortfolio]

Biotransformation of pharmaceuticals by ammonia oxidizing bacteria in wastewater treatment processes.

Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Photosynthetic sensitivity of phytoplankton to commonly used pharmaceuticals and its dependence on cellular phosphorus status.

Recently pharmaceuticals have become significant environmental pollutants in aquatic ecosystems, that could affect primary producers such as microalgae. Here we analyzed the effect of pharmaceuticals ...

Occurrence of pharmaceuticals and cocaine in a Brazilian coastal zone.

The present study determined environmental concentrations of pharmaceuticals, cocaine, and the main human metabolite of cocaine in seawater sampled from a subtropical coastal zone (Santos, Brazil). Th...

Fate of pharmaceuticals and pesticides in fly larvae composting.

A novel and efficient organic waste management strategy currently gaining great attention is fly larvae composting. High resource recovery efficiency can be achieved in this closed-looped system, but ...

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

An Open-Label, Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use DSXS topical product (Taro Pharmaceuticals U.S.A., Inc.) in Patients with Moderate to Seve...

T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.

This study evaluates the frequency of occurrence, severity, and response to treatment by a chemical agent, notably the dimerizer AP1903 (Bellicum Pharmaceuticals compagny), in the case of ...

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Following Treatment with DSXS (Taro Pharmaceuticals U.S.A., Inc.) in Patients with Plaque Psoriasis

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

The primary objective of this study is to continue to provide Darunavir (DRV) to pediatric patients who previously received DRV in any of three pediatric clinical studies sponsored by Tibo...

Companies [5 Associated Companies listed on BioPortfolio]

Iroko Pharmaceuticals, LLC

Iroko is a pharmaceutical company focused on specialty therapeutic areas. The company acquires, develops and maximizes the potential of currently marketed products on a global bas...

Iroko Pharmaceuticals, LLC and SynopiaRx LLC

Iroko is a pharmaceutical company focused on the development and commercialization of innovative specialty therapeutic products. The company acquires, develops and maximizes the p...

Iroko Cardio International Sàrl

IROKO Cardio has been founded to organize and support the commercial effort for Aggrastat. In close cooperation with our worldwide distribution partners, we aim to provide state o...

Iroko Pharmaceuticals Inc.

Iroko Pharmaceuticals, LLC and Aptuit Inc.

More Information about "Iroko Pharmaceuticals, LLC" on BioPortfolio

We have published hundreds of Iroko Pharmaceuticals, LLC news stories on BioPortfolio along with dozens of Iroko Pharmaceuticals, LLC Clinical Trials and PubMed Articles about Iroko Pharmaceuticals, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Iroko Pharmaceuticals, LLC Companies in our database. You can also find out about relevant Iroko Pharmaceuticals, LLC Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record